These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9168448)

  • 41. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S
    Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
    Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
    Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab.
    Quach H; Januszewicz H; Westerman D
    Haematologica; 2005 Nov; 90 Suppl():ECR26. PubMed ID: 16266917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine.
    Dearden CE; Matutes E; Hilditch BL; Swansbury GJ; Catovsky D
    Br J Haematol; 1999 Aug; 106(2):515-9. PubMed ID: 10460614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience.
    Öngören Ş; Eşkazan AE; Berk S; Elverdi T; Salihoğlu A; Ar MC; Başlar Z; Aydın Y; Tüzüner N; Soysal T
    Turk J Haematol; 2017 Dec; 34(4):291-299. PubMed ID: 29199176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
    Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K
    Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hairy cell leukaemia with advanced treatment - a case report.
    Momen A; Sarker CB; Siddiqui NI; Huq MH; Jamal MF; Talukder SI; Rahman KM
    Mymensingh Med J; 2003 Jul; 12(2):134-7. PubMed ID: 12894049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retreatment with 2-CdA of progressed HCL patients.
    Lauria F; Benfenati D; Raspadori D; Rondelli D; Ventura MA; Pileri S; Sabattini E; Poggi S; Benni M; Tura S
    Leuk Lymphoma; 1994; 14 Suppl 1():143-5. PubMed ID: 7820047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
    Góra-Tybor J; Robak T
    Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of hairy cell leukemia variant.
    Robak T
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():53-6. PubMed ID: 21599606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 55. New rearrangement pattern after treatment of hairy-cell leukemia with 2-chlorodeoxyadenosine.
    Schirmer M; Haun M; Grünewald K; Geisen F; Hilbe W; Thaler J; Konwalinka G
    Acta Haematol; 2000; 103(2):109-11. PubMed ID: 10838455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunobiological treatments of hairy-cell leukaemia.
    Kreitman RJ; Pastan I
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):117-33. PubMed ID: 12670470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.
    Tallman MS; Hakimian D; Rademaker AW; Zanzig C; Wollins E; Rose E; Peterson LC
    Blood; 1996 Sep; 88(6):1954-9. PubMed ID: 8822913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hairy cell leukemia treated with cladribine].
    Ghanima W; Heldal D; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1094-7. PubMed ID: 12043051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin.
    Saven A; Piro LD
    Ann Intern Med; 1993 Aug; 119(4):278-83. PubMed ID: 8101069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
    Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
    Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.